These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8566369)

  • 21. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.
    Lu NZ; Eshleman AJ; Janowsky A; Bethea CL
    Mol Psychiatry; 2003 Mar; 8(3):353-60. PubMed ID: 12660809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The serotonin transporter from human brain: purification and partial characterization.
    Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB
    Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible existence of quaternary structure in the high-affinity serotonin transport complex.
    Chang AS; Starnes DM; Chang SM
    Biochem Biophys Res Commun; 1998 Aug; 249(2):416-21. PubMed ID: 9712711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
    J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.
    Barker EL; Perlman MA; Adkins EM; Houlihan WJ; Pristupa ZB; Niznik HB; Blakely RD
    J Biol Chem; 1998 Jul; 273(31):19459-68. PubMed ID: 9677366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.
    Naudon L; Leroux-Nicollet I; Boulay D; Costentin J
    J Neural Transm (Vienna); 2001; 108(4):431-44. PubMed ID: 11475010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The research progress on 5-hydroxytryptamine transporter].
    Zhang XM; Yan SQ
    Sheng Li Ke Xue Jin Zhan; 1997 Oct; 28(4):345-8. PubMed ID: 11038689
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic amitriptyline administration increases serotonin transporter binding sites in the hippocampus of aged rats.
    Yau JL; Kelly PA; Olsson T; Noble J; Seckl JR
    Neurosci Lett; 1999 Feb; 261(3):183-5. PubMed ID: 10081979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.
    Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S
    Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carrier-mediated serotonin release induced by d-fenfluramine: studies with human neuroblastoma cells transfected with a rat serotonin transporter.
    Cinquanta M; Ratovitski T; Crespi D; Gobbi M; Mennini T; Simantov R
    Neuropharmacology; 1997 Jun; 36(6):803-9. PubMed ID: 9225308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional distribution of 5-HT transporters in the brain of wild type and 'Purkinje cell degeneration' mutant mice: a quantitative autoradiographic study with [3H]citalopram.
    Le Marec N; Hébert C; Amdiss F; Botez MI; Reader TA
    J Chem Neuroanat; 1998 Sep; 15(3):155-71. PubMed ID: 9797073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
    Duncan MJ; Hensler JG
    Neuropharmacology; 2002 Jul; 43(1):36-44. PubMed ID: 12213257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor.
    Hansen HH; Mikkelsen JD
    Eur J Pharmacol; 1998 Jul; 352(2-3):307-15. PubMed ID: 9716368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selective serotonin reuptake inhibitors for behavior disorders].
    Miyajima T; Furusho J
    No To Hattatsu; 2004 Mar; 36(2):147-50. PubMed ID: 15031991
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies.
    Qian Y; Melikian HE; Rye DB; Levey AI; Blakely RD
    J Neurosci; 1995 Feb; 15(2):1261-74. PubMed ID: 7869097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.